Infertility, Male Infertility
Conditions
Keywords
Infertility, Male Infertility, Comorbidity
Brief summary
By applying a system medicine approach, the project aims to identify new biomarkers and/or prognostic tools aimed at developing personalized strategies to prevent the onset of comorbidities in infertile men.
Detailed description
By applying a system medicine approach, the project aims to identify new biomarkers and/or prognostic tools aimed at developing personalized strategies to prevent the onset of comorbidities in infertile men. The findings will provide new insights into the relationship between male infertility and somatic health, and shed light on the role of the microbiome in modulating the activity of the immune system. A signature of lack of immunological tolerance and biomarkers could be useful to predict future oncologic and non-oncological comorbidities in infertile men. This will let the development of a more clinically reliable and cost-effective personalized primary/secondary prevention strategy in a population at high risk of clinically relevant diseases.
Interventions
OTHERObservation and evaluation of clinical parameters in the two cohorts
During medical history evaluation, all factors that could negatively affect male fertility, like prevalent comorbidities, previous testis surgery, and any disorder affecting testicular function will be investigated in fertile and infertile men. Moreover, family history will be deeply investigated, including fertility status and prevalence of malignant Non Communicables Diseases. A comprehensive physical examination will be performed on each infertile and fertile man.
Sponsors
IRCCS San Raffaele
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
MALE
Age
18 Years to No maximum
Inclusion criteria
* Signature of the informed consent; * Be adults aged \> 18; * Caucasian race; * Documented diagnosis of primary male infertility with pure male factor;
Exclusion criteria
* Failure to obtain informed consent; * Patients with a known history of haematological disease; * Patients undergoing antibiotic treatments in the last 6 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Medical anamnesis | Baseline | Data collection on Charlson Comorbidity Index (CCI), partner's age, partner's health status; |
| Objective examination | Baseline | presence of varicocele; testicular size and number |
| Testosterone | Baseline | data on testosterone (ng/dL) |
| Genetic profile | Baseline | Data on karyotype and microdeletions of the Y chromosome |
| Semen volume | Baseline | Semen volume (ml) |
| Body mass index | Baseline | Dataon Body mass index |
| Follicle-stimulating hormone | Baseline | Data on follicle-stimulating hormone (mIU/ml) |
| Luteinizing hormone | Baseline | Data on luteinizing hormone (mIU/dl) |
| Anti-Müllerian hormone | Baseline | Data on Anti-Müllerian hormone (ng/ml) |
| Inhibin B | Baseline | Data on Inhibin B (UI/mL) |
| Prolactin | Baseline | Data on Prolactin (µg/l) |
| Thyroid-stimulating hormone | Baseline | Data on thyroid-stimulating hormone (mU/L) |
| Osteocalcin levels | Baseline | Data on osteocalcin levels (ng/ml) |
| Semen concentration | Baseline | number of spermatozoa (million/ml) |
| Spermatozoa motility and morphology | Baseline | motility and morphology of spermatozoa (%) |
Countries
Italy
Contacts
Primary ContactAndrea Salonia, MD
Backup ContactAlessia d'Arma, PhD
Outcome results
None listed